42 CFR Part 447, Subpart I - Payment for Drugs
prev | next
- § 447.500 Basis and purpose.
- § 447.502 Definitions.
- § 447.504 Determination of average manufacturer price.
- § 447.505 Determination of best price.
- § 447.506 Authorized generic drugs.
- § 447.507 Identification of inhalation, infusion, instilled, implanted, or injectable drugs (5i drugs).
- § 447.508 Exclusion from best price of certain sales at a nominal price.
- § 447.509 Medicaid drug rebates (MDR).
- § 447.510 Requirements for manufacturers.
- § 447.511 Requirements for States.
- § 447.512 Drugs: Aggregate upper limits of payment.
- § 447.514 Upper limits for multiple source drugs.
- § 447.516 Upper limits for drugs furnished as part of services.
- § 447.518 State plan requirements, findings, and assurances.
- § 447.520 Federal Financial Participation (FFP): Conditions relating to physician-administered drugs.
- § 447.522 Optional coverage of investigational drugs and other drugs not subject to rebate.
Source:
81 FR 5347, Feb. 1, 2016, unless otherwise noted.